Patient experience
Item
1. Has the patient experienced any of the following since randomization:
text
C0596545 (UMLS CUI [1,1])
C0030705 (UMLS CUI [1,2])
Dizziness or Lightheadedness
Item
Dizziness or Lightheadedness
boolean
C0012833 (UMLS CUI [1])
C0220870 (UMLS CUI [2])
Fainting
Item
Fainting
boolean
C0039070 (UMLS CUI [1])
Headache
Item
Headache during first week of study drug administration
boolean
C0018681 (UMLS CUI [1])
Item
If headache occurred please indicate how it was treated (indicate all that apply):
integer
C0087111 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Code List
If headache occurred please indicate how it was treated (indicate all that apply):
CL Item
Down titration of study medication A (2)
Outcome Events or Serious Adverse Events
Item
2. Have any Outcome Events or Serious Adverse Events been experienced? (See instructions on facing page)
boolean
C1705586 (UMLS CUI [1])
C0877248 (UMLS CUI [2])
Item
if "Yes" please indicate all that apply
integer
C2348235 (UMLS CUI [1])
Code List
if "Yes" please indicate all that apply
CL Item
Myocardial Infarction (2)
CL Item
New or worsening congestive heart failure (CHF) (4)
CL Item
Other designated vascular event (5)
CL Item
Hemorrhagic Event (6)
CL Item
Thrombotic Thrombocytopenia purpura (7)
CL Item
Newly diagnosed diabetes (9)
Signature of Investigator or Sub-Investigator
Item
4. Signature of Investigator or Sub-Investigator
text
C2346576 (UMLS CUI [1])
Date of Signature
Item
Date of Signature (dd mon yy)
date
C1519316 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])